HOLX News and Press, Hologic Inc. From 07/06/21

Hologic upgraded on tuck-in M&A strategyEvercore ISI is upgrading share of Hologic ([[HOLX]] -0.4%) to outperform with a $78 price target (~15% upside).The firm says that the women's health and diagnostics player is poised for future tuck-in acquisitions, funded with profits from its COVI...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2021 on Wednesday, July 28, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern...

SusanneB/E+ via Getty Images As the third quarter gets underway, BTIG has issued its list of top large-cap stock picks. The picks are the highest-conviction stocks over a 12-month time horizon starting H2 2021. Among sectors, BTIG is overweight three areas: Energy (XLE), Financials (XLF) and ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Hoptocopter/E+ via Getty Images Citing a peer-reviewed study published in the Journal of Infectious Diseases, the National Institute of Health says that both rapid antigen tests and PCR molecular tests have a high rate of sensitivity in detecting COVID-19. The PCR tests, considered the g...

Yuichiro Chino/Moment via Getty Images According to Bank of America's recent survey, most institutional investors consider themselves as quant investors of some kind. BofA Securities issued its 30th Annual Institutional Factor Survey last week. "Since 2013 when we began asking investors wheth...

Hologic (HOLX) has received CE mark for its new Aptima CMV Quant assay in Europe.This assay, which quantifies the viral load of human cytomegalovirus ((CMV)), is intended for use to aid in the diagnosis and management of solid-organ transplant patients and hematopoietic stem cell transplant p...

--Aptima ® CMV Quant Assay is Hologic’s first test for transplant pathogen monitoring-- Hologic, Inc. (Nasdaq: HOLX) has received CE mark for its new Aptima ® CMV Quant assay in Europe, the Company announced today. This assay, which quantifies th...

The reopening economy and supportive fiscal and monetary policies have been driving the performance of some quality growth stocks despite investors’ sector rotation out of the growth class and other factors that are driving market volatility. Among examples of this are Hologic (HOLX), ...

Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of Mobidiag Oy, an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately $808 million. “Closing the acqui...